141 related articles for article (PubMed ID: 21621841)
1. Effects of pituitary adenylate cyclase activating polypeptide in the urinary system, with special emphasis on its protective effects in the kidney.
Reglodi D; Kiss P; Horvath G; Lubics A; Laszlo E; Tamas A; Racz B; Szakaly P
Neuropeptides; 2012 Apr; 46(2):61-70. PubMed ID: 21621841
[TBL] [Abstract][Full Text] [Related]
2. The effects of pituitary adenylate cyclase activating polypeptide in renal ischemia/reperfusion.
László E; Kiss P; Horváth G; Szakály P; Tamás A; Reglődi D
Acta Biol Hung; 2014 Dec; 65(4):369-78. PubMed ID: 25475976
[TBL] [Abstract][Full Text] [Related]
3. The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney.
Horvath G; Opper B; Reglodi D
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591326
[TBL] [Abstract][Full Text] [Related]
4. Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro.
Horvath G; Mark L; Brubel R; Szakaly P; Racz B; Kiss P; Tamas A; Helyes Z; Lubics A; Hashimoto H; Baba A; Shintani N; Furjes G; Nemeth J; Reglodi D
Neurosci Lett; 2010 Jan; 469(1):70-4. PubMed ID: 19932736
[TBL] [Abstract][Full Text] [Related]
5. Mice deficient in neuropeptide PACAP demonstrate increased sensitivity to in vitro kidney hypoxia.
Horvath G; Racz B; Szakaly P; Kiss P; Laszlo E; Hau L; Tamas A; Helyes Z; Lubics A; Hashimoto H; Baba A; Reglodi D
Transplant Proc; 2010; 42(6):2293-5. PubMed ID: 20692466
[TBL] [Abstract][Full Text] [Related]
6. Ischemia/reperfusion-induced Kidney Injury in Heterozygous PACAP-deficient Mice.
Laszlo E; Varga A; Kovacs K; Jancso G; Kiss P; Tamas A; Szakaly P; Fulop B; Reglodi D
Transplant Proc; 2015 Sep; 47(7):2210-5. PubMed ID: 26361682
[TBL] [Abstract][Full Text] [Related]
7. Renoprotection with pituitary adenylate cyclase-activating polypeptide in cyclosporine A-induced nephrotoxicity.
Khan AM; Li M; Brant E; Maderdrut JL; Majid DS; Simon EE; Batuman V
J Investig Med; 2011 Jun; 59(5):793-802. PubMed ID: 21383633
[TBL] [Abstract][Full Text] [Related]
8. Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells.
Horvath G; Brubel R; Kovacs K; Reglodi D; Opper B; Ferencz A; Szakaly P; Laszlo E; Hau L; Kiss P; Tamas A; Racz B
J Mol Neurosci; 2011 Jan; 43(1):67-75. PubMed ID: 20676802
[TBL] [Abstract][Full Text] [Related]
9. Changes in pituitary adenylate cyclase-activating polypeptide following renal ischemia-reperfusion in rats.
Szakaly P; Horvath G; Kiss P; Laszlo E; Farkas J; Furjes G; Nemeth J; Reglodi D
Transplant Proc; 2010; 42(6):2283-6. PubMed ID: 20692463
[TBL] [Abstract][Full Text] [Related]
10. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) show increased susceptibility to in vivo renal ischemia/reperfusion injury.
Szakaly P; Laszlo E; Kovacs K; Racz B; Horvath G; Ferencz A; Lubics A; Kiss P; Tamas A; Brubel R; Opper B; Baba A; Hashimoto H; Farkas J; Matkovits A; Magyarlaki T; Helyes Z; Reglodi D
Neuropeptides; 2011 Apr; 45(2):113-21. PubMed ID: 21211837
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury.
Li M; Balamuthusamy S; Khan AM; Maderdrut JL; Simon EE; Batuman V
Peptides; 2010 Apr; 31(4):592-602. PubMed ID: 20034524
[TBL] [Abstract][Full Text] [Related]
12. Protective Effect of PACAP on Ischemia/Reperfusion-Induced Kidney Injury of Male and Female Rats: Gender Differences.
Laszlo E; Juhasz T; Varga A; Czibere B; Kovacs K; Degrell P; Horvath G; Jancso G; Szakaly P; Tamas A; Reglodi D
J Mol Neurosci; 2019 Jul; 68(3):408-419. PubMed ID: 30443839
[TBL] [Abstract][Full Text] [Related]
13. Effects of PACAP on survival and renal morphology in rats subjected to renal ischemia/reperfusion.
Szakaly P; Kiss P; Lubics A; Magyarlaki T; Tamas A; Racz B; Lengvari I; Toth G; Reglodi D
J Mol Neurosci; 2008 Nov; 36(1-3):89-96. PubMed ID: 18478450
[TBL] [Abstract][Full Text] [Related]
14. PACAP is an endogenous protective factor-insights from PACAP-deficient mice.
Reglodi D; Kiss P; Szabadfi K; Atlasz T; Gabriel R; Horvath G; Szakaly P; Sandor B; Lubics A; Laszlo E; Farkas J; Matkovits A; Brubel R; Hashimoto H; Ferencz A; Vincze A; Helyes Z; Welke L; Lakatos A; Tamas A
J Mol Neurosci; 2012 Nov; 48(3):482-92. PubMed ID: 22528455
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
[TBL] [Abstract][Full Text] [Related]
16. Effects of PACAP on mitochondrial apoptotic pathways and cytokine expression in rats subjected to renal ischemia/reperfusion.
Horvath G; Racz B; Reglodi D; Kovacs K; Kiss P; Gallyas F; Bognar Z; Szabo A; Magyarlaki T; Laszlo E; Lubics A; Tamas A; Toth G; Szakaly P
J Mol Neurosci; 2010 Nov; 42(3):411-8. PubMed ID: 20229361
[TBL] [Abstract][Full Text] [Related]
17. Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells.
Kasica N; Podlasz P; Sundvik M; Tamas A; Reglodi D; Kaleczyc J
Neurotox Res; 2016 Nov; 30(4):633-647. PubMed ID: 27557978
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase-activating polypeptide ameliorates vascular dysfunction induced by hyperglycaemia.
Solymar M; Ivic I; Balasko M; Fulop BD; Toth G; Tamas A; Reman G; Koller A; Reglodi D
Diab Vasc Dis Res; 2018 Jul; 15(4):277-285. PubMed ID: 29466879
[TBL] [Abstract][Full Text] [Related]
19. Effects of pituitary adenylate cyclase activating polypeptide on small intestinal INT 407 cells.
Illes A; Opper B; Reglodi D; Kerenyi M; Czetany P; Boronkai A; Schafer E; Toth G; Fabian E; Horvath G
Neuropeptides; 2017 Oct; 65():106-113. PubMed ID: 28698051
[TBL] [Abstract][Full Text] [Related]
20. Effects of PACAP and preconditioning against ischemia/reperfusion-induced cardiomyocyte apoptosis in vitro.
Roth E; Wéber G; Kiss P; Horváth G; Tóth G; Gasz B; Ferencz A; Gallyas F; Reglodi D; Rácz B
Ann N Y Acad Sci; 2009 Apr; 1163():512-6. PubMed ID: 19456402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
